JP2012046538A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012046538A5 JP2012046538A5 JP2011226655A JP2011226655A JP2012046538A5 JP 2012046538 A5 JP2012046538 A5 JP 2012046538A5 JP 2011226655 A JP2011226655 A JP 2011226655A JP 2011226655 A JP2011226655 A JP 2011226655A JP 2012046538 A5 JP2012046538 A5 JP 2012046538A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- peptide analog
- seq
- target muscle
- promote
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 claims 5
- 210000003205 muscle Anatomy 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 210000002161 motor neuron Anatomy 0.000 claims 3
- 210000002569 neuron Anatomy 0.000 claims 3
- 230000035755 proliferation Effects 0.000 claims 3
- 230000007832 reinnervation Effects 0.000 claims 3
- 230000012010 growth Effects 0.000 claims 2
- 210000005036 nerve Anatomy 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 230000004083 survival effect Effects 0.000 claims 2
- 108010025020 Nerve Growth Factor Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 235000003170 nutritional factors Nutrition 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44177203P | 2003-01-21 | 2003-01-21 | |
| US60/441,772 | 2003-01-21 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010215438A Division JP4913895B2 (ja) | 2003-01-21 | 2010-09-27 | Ｍｎｔｆペプチドおよび組成物ならびに使用の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012046538A JP2012046538A (ja) | 2012-03-08 |
| JP2012046538A5 true JP2012046538A5 (enExample) | 2012-04-19 |
Family
ID=32771972
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006501057A Withdrawn JP2006516287A (ja) | 2003-01-21 | 2004-01-21 | Ｍｎｔｆペプチドおよび組成物ならびに使用の方法 |
| JP2010215438A Expired - Fee Related JP4913895B2 (ja) | 2003-01-21 | 2010-09-27 | Ｍｎｔｆペプチドおよび組成物ならびに使用の方法 |
| JP2011226655A Pending JP2012046538A (ja) | 2003-01-21 | 2011-10-14 | Ｍｎｔｆペプチドおよび組成物ならびに使用の方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006501057A Withdrawn JP2006516287A (ja) | 2003-01-21 | 2004-01-21 | Ｍｎｔｆペプチドおよび組成物ならびに使用の方法 |
| JP2010215438A Expired - Fee Related JP4913895B2 (ja) | 2003-01-21 | 2010-09-27 | Ｍｎｔｆペプチドおよび組成物ならびに使用の方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7183373B2 (enExample) |
| EP (1) | EP1587526B1 (enExample) |
| JP (3) | JP2006516287A (enExample) |
| AT (1) | ATE530191T1 (enExample) |
| AU (1) | AU2004205659B2 (enExample) |
| CA (1) | CA2506855C (enExample) |
| DK (1) | DK1587526T3 (enExample) |
| ES (1) | ES2375797T3 (enExample) |
| WO (1) | WO2004065410A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6841531B2 (en) | 1996-09-27 | 2005-01-11 | Genervon Biopharmaceuticals Llc | Methods and use of motoneuronotrophic factors |
| DK1587526T3 (da) * | 2003-01-21 | 2012-02-06 | Genervon Biopharmaceuticals Llc | MNTF-peptider og sammensætninger og anvendelsesmåder |
| JP5270362B2 (ja) * | 2005-11-10 | 2013-08-21 | ジェナボン バイオファーマシューティカルズ エルエルシー | 幹細胞のｍｎｔｆ分化および成長 |
| US8340193B2 (en) * | 2006-08-04 | 2012-12-25 | Microsoft Corporation | Wyner-Ziv and wavelet video coding |
| AU2007317730B2 (en) * | 2006-11-10 | 2014-01-09 | Genervon Biopharmaceuticals Llc | Methods of treating neuronal disorders using MNTF peptides and analogs thereof |
| EP2000134A1 (en) * | 2007-06-06 | 2008-12-10 | Neuraxo Biopharmaceuticals GmbH | Use of a substance for the improvement of pns lesions |
| US20090233295A1 (en) * | 2008-01-29 | 2009-09-17 | Elias Georges | Trim59 directed diagnostics for neoplastic disease |
| AU2009217269B2 (en) * | 2008-02-21 | 2014-10-02 | Dermacare Neuroscience Institute | Cosmetic and dermatological formulations of MNTF peptides |
| CN101951942B (zh) * | 2008-02-21 | 2014-09-03 | 健能万生物制药公司 | Mntf肽组合物及使用方法 |
| WO2016210123A1 (en) | 2015-06-26 | 2016-12-29 | Genervon Biopharmaceuticals, LLC | Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease |
| JP7504367B2 (ja) | 2021-05-18 | 2024-06-24 | 株式会社Ｌｔｔバイオファーマ | 抗癌剤の投与に伴う障害を治療又は予防するための医薬組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6841531B2 (en) * | 1996-09-27 | 2005-01-11 | Genervon Biopharmaceuticals Llc | Methods and use of motoneuronotrophic factors |
| US6309877B1 (en) * | 1996-09-27 | 2001-10-30 | Km Biotech, Inc. | Polynucleotides encoding motoneuronotrophic factors |
| DK1587526T3 (da) * | 2003-01-21 | 2012-02-06 | Genervon Biopharmaceuticals Llc | MNTF-peptider og sammensætninger og anvendelsesmåder |
-
2004
- 2004-01-21 DK DK04704005.0T patent/DK1587526T3/da active
- 2004-01-21 EP EP04704005A patent/EP1587526B1/en not_active Expired - Lifetime
- 2004-01-21 WO PCT/US2004/001468 patent/WO2004065410A2/en not_active Ceased
- 2004-01-21 JP JP2006501057A patent/JP2006516287A/ja not_active Withdrawn
- 2004-01-21 AU AU2004205659A patent/AU2004205659B2/en not_active Ceased
- 2004-01-21 US US10/541,343 patent/US7183373B2/en not_active Expired - Lifetime
- 2004-01-21 CA CA2506855A patent/CA2506855C/en not_active Expired - Lifetime
- 2004-01-21 ES ES04704005T patent/ES2375797T3/es not_active Expired - Lifetime
- 2004-01-21 AT AT04704005T patent/ATE530191T1/de active
-
2007
- 2007-01-25 US US11/657,815 patent/US7795215B2/en not_active Expired - Lifetime
-
2010
- 2010-09-27 JP JP2010215438A patent/JP4913895B2/ja not_active Expired - Fee Related
-
2011
- 2011-10-14 JP JP2011226655A patent/JP2012046538A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012046538A5 (enExample) | ||
| JP2014240404A5 (enExample) | ||
| CN103804482B (zh) | 一种抗菌肽及其应用 | |
| NZ611878A (en) | Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides | |
| JP2017529849A5 (enExample) | ||
| MX366968B (es) | Molecula de union al antigeno que induce la inmunorespuesta al antigeno objetivo. | |
| JP2010534684A5 (enExample) | ||
| JP2011177189A5 (enExample) | ||
| JP2013521795A5 (enExample) | ||
| JP2016527891A5 (enExample) | ||
| RU2012120772A (ru) | Варианты синтетической фитазы | |
| WO2013016724A3 (en) | Decarboxylase proteins with high keto-isovalerate decarboxylase activity | |
| MX352195B (es) | Genes que proporcionan resistencia al mildiú polvoroso en cucumis melo. | |
| Pinto et al. | Utilization of antimicrobial peptides, analogues and mimics in creating antimicrobial surfaces and bio-materials | |
| JP2015533791A5 (enExample) | ||
| JP2013531491A5 (enExample) | ||
| EP2578597A4 (en) | NOVEL CYCLIC PEPTIDE COMPOUND, PROCESS FOR PRODUCTION THEREOF, ANTI-INFECTIOUS AGENT, FRACTION CONTAINING ANTIBIOTICS, ANTIBIOTICS, PROCESS FOR PRODUCTION OF ANTIBIOTICS, MICROORGANISM PRODUCING ANTIBIOTICS AND ANTIBIOTICS PRODUCED THEREBY | |
| NZ610620A (en) | Inhibitors of apoptosis and uses thereof | |
| JP2014532722A5 (enExample) | ||
| FI20115870A0 (fi) | Neuroprotektiiviset soluihin tunkeutuvat peptidit | |
| MY169650A (en) | Crystalline recombinant interferon with altered spatial configuration,three-dimensional structure and uses thereof | |
| JP2014527801A5 (enExample) | ||
| JP2010265269A5 (enExample) | ||
| JP2010533735A5 (enExample) | ||
| JP2013504519A5 (enExample) |